1 September 2022
Transition to annual admission
“The master gives you the full perspective and understanding of the drug development phases. There are not many master’s programmes offering a full package like this.”
- Ea Pettersson, Head of Biopharmaceutical QC, Novo Nordisk.
“If you do not need the whole package, you could just enrol in one of the great courses. I very much like that you have the ability to hand pick according to your needs.”
- Lene Sønderbye Kjærulff, Project Manager, H. Lundbeck A/S.
